Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial.
暂无分享,去创建一个
P. Ellis | M. Piccart | J. Bogaerts | E. Blot | D. Cameron | T. Čufer | P. Canney | R. Coleman | G. Basaran | J. Vermorken | S. Marréaud | B. Pajk